Your browser doesn't support javascript.
loading
Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate.
Hutchison, Alastair; Whelton, Andrew; Thadhani, Ravi; Achenbach, Heinrich; Vergani, Andrea; Wu, Jingyang; Hall, Gillian.
Afiliação
  • Hutchison A; Renal Dialysis Unit, Manchester Royal Infirmary and Manchester Academic Health Science Centre, Manchester, United Kingdomalastair.hutchison@dchft.nhs.uk.
  • Whelton A; School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Thadhani R; Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Achenbach H; Clinical Research and Development, Shire, Zug, Switzerland.
  • Vergani A; Clinical Research and Development, Shire, Lexington, Massachusetts, USA.
  • Wu J; Biostatistics, Shire, Lexington, Massachusetts, USA.
  • Hall G; Gillian Hall Epidemiology Ltd., London, United Kingdom.
Nephron ; 140(4): 265-274, 2018.
Article em En | MEDLINE | ID: mdl-30352437
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Renais / Osso e Ossos / Falência Renal Crônica / Lantânio Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Renais / Osso e Ossos / Falência Renal Crônica / Lantânio Idioma: En Ano de publicação: 2018 Tipo de documento: Article